Published July 24, 2026 | Version 1.0.0

Bioluminate, Osprey and Covalent Docking data - Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir

Description

Bioluminate, Osprey, and Covalent docking Raw data

Files

A171S.zip

Files (74.4 MB)

Name Size
md5:b83b57fc91c0ccd602f8d64c7e3808c1
6.0 MB Preview Download
md5:121549f016f60c71fbe973d29da8c124
24.7 MB Preview Download
md5:4704883ab26257408a4cf565592c916e
43.7 MB Preview Download

Additional details

Funding

FWF Austrian Science Fund
Computational identification of drug resistance mutations P34376